Blog

FDA Warns Consumers About the Dangers of Viekira Pak

January 1, 1970 · FLEMING | NOLEN | JEZ, L.L.P.

The United States Food and Drug Administration (FDA) released a safety warning in 2016 warning consumers that the use of Viekira Pak, a hepatitis C medication, can cause serious liver damage, acute liver failure, liver transplant, multi-organ failure and death, particularly in patients with existing liver conditions. Viekira Pak is a fixed-dose combination of ritonavir, paritaprevir, ombitasvir, and dasabuvir that…
read more